MAXIMUS (MMS) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

MAXIMUS (NYSE:MMS) released its earnings results on Thursday. The health services provider reported $0.78 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.01, Morningstar.com reports. MAXIMUS had a return on equity of 23.97% and a net margin of 8.54%. The company had revenue of $623.10 million during the quarter, compared to the consensus estimate of $624.36 million. During the same quarter last year, the company earned $0.71 earnings per share. MAXIMUS’s quarterly revenue was up 2.6% compared to the same quarter last year. MAXIMUS updated its FY18 guidance to $3.30-3.50 EPS.

MAXIMUS (NYSE MMS) traded down $1.12 during mid-day trading on Friday, reaching $62.85. The company’s stock had a trading volume of 219,167 shares, compared to its average volume of 469,614. MAXIMUS has a 52 week low of $55.18 and a 52 week high of $72.71. The stock has a market cap of $4,255.17, a P/E ratio of 20.10, a PEG ratio of 2.45 and a beta of 1.21.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be issued a dividend of $0.045 per share. The ex-dividend date is Wednesday, February 14th. This represents a $0.18 annualized dividend and a yield of 0.29%. MAXIMUS’s dividend payout ratio is presently 5.66%.

In other MAXIMUS news, CEO Richard A. Montoni sold 30,000 shares of MAXIMUS stock in a transaction that occurred on Thursday, December 7th. The stock was sold at an average price of $69.25, for a total transaction of $2,077,500.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, General Counsel David Francis sold 3,900 shares of MAXIMUS stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $63.97, for a total value of $249,483.00. Following the sale, the general counsel now owns 15,090 shares in the company, valued at $965,307.30. The disclosure for this sale can be found here. Insiders have sold a total of 71,417 shares of company stock worth $4,902,785 over the last 90 days. 3.10% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Arizona State Retirement System increased its stake in MAXIMUS by 27.6% in the 4th quarter. Arizona State Retirement System now owns 46,885 shares of the health services provider’s stock valued at $3,356,000 after buying an additional 10,144 shares during the last quarter. Capital Fund Management S.A. increased its stake in MAXIMUS by 4.4% in the 4th quarter. Capital Fund Management S.A. now owns 104,176 shares of the health services provider’s stock valued at $7,457,000 after buying an additional 4,418 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in MAXIMUS by 9.0% in the 4th quarter. The Manufacturers Life Insurance Company now owns 154,243 shares of the health services provider’s stock valued at $11,040,000 after buying an additional 12,717 shares during the last quarter. New Mexico Educational Retirement Board purchased a new stake in MAXIMUS in the 4th quarter valued at about $1,152,000. Finally, Capital One National Association purchased a new stake in MAXIMUS in the 4th quarter valued at about $213,000. Institutional investors and hedge funds own 96.44% of the company’s stock.

A number of equities research analysts have commented on MMS shares. Canaccord Genuity reduced their target price on MAXIMUS from $62.00 to $61.00 and set a “hold” rating for the company in a report on Friday, November 10th. Zacks Investment Research downgraded MAXIMUS from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. Finally, Maxim Group lifted their price objective on MAXIMUS from $66.00 to $69.00 and gave the stock a “hold” rating in a report on Thursday. One equities research analyst has rated the stock with a sell rating and six have given a hold rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $67.00.

WARNING: This report was posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/02/08/maximus-mms-posts-quarterly-earnings-results-beats-expectations-by-0-12-eps.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Earnings History for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply